The New York Times

Isomorphic Labs, Google’s A.I. Drug Business, Raises $600 Million

The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital as a backer. By Michael J. de la Merced Reporting from London Over the ...